Showing 1–16 of 18 results
Adenovirus DNA, Quantitative Real-Time PCR is a highly sensitive and specific molecular diagnostic test designed for the rapid and accurate quantification of adenovirus DNA in clinical samples. Utilizing real-time PCR technology, it ensures precise viral load measurement, enabling early detection and effective monitoring of infections.
Sample Type : Stool
Methodology : Real-time PCR
TAT : 10 Days
Anti-Varicella Zoster Antibodies, IgG is a high-quality immunoassay reagent designed for the precise detection of IgG antibodies against the Varicella-Zoster Virus (VZV). It enables accurate diagnosis of past infections, immunity status, and vaccine response.
Sample Type : Serum
Methodology : Indirect immunofluorescence or Enzyme-immunoassay
TAT : 1-3 Days
Aspergillus IgM Antibodies are essential diagnostic tools for detecting early-stage Aspergillus infections, particularly in immunocompromised patients. These antibodies enable rapid and specific identification of recent or active infections, aiding in timely clinical intervention. Key features include high sensitivity and specificity, ensuring accurate detection with minimal cross-reactivity.
Sample Type : Serum
Methodology : Enzyme-immunoassay
TAT : 15 Days
The Bacterial Vaginosis DNA, Quant, RT-PCR test is an advanced molecular diagnostic tool designed for the accurate detection and quantification of bacterial vaginosis (BV)-associated pathogens. Utilizing real-time PCR (RT-PCR) technology, it provides rapid, precise, and quantitative analysis of key bacterial species linked to BV, including Gardnerella vaginalis, Atopobium vaginae, and others.
Sample Type : Vaginal Swab
Methodology : Real-time polymerase chain reaction (PCR)
TAT : 3 Days
Sample Type : Random Urine
Methodology : Immunochromatography
TAT : 1 Day
Culture & Sensitivity – Fluid is a diagnostic solution designed for the accurate detection and identification of microbial pathogens in body fluids.
Sample Type : Fluid
Methodology : Bacteriology Culture
TAT : 3 Days
Direct Microscopic Examination is a rapid diagnostic method used to visually detect microorganisms, cells, and other microscopic elements directly from clinical specimens.
Sample Type : Swab
Methodology : Microscopy
TAT : 1 Day
Fine Needle Aspiration (Slides Fluid) is a specialized diagnostic test designed to collect and analyze cellular material from various body sites.
Sample Type : Fixed Smears + Fluid
Methodology : Cytology
TAT : 3 Days
Flunitrazepam (Rohypnol) Serum Analysis via HPLC-DAD offers precise detection and quantification of Flunitrazepam in serum using high-performance liquid chromatography with diode-array detection (HPLC-DAD).
Sample Type : Serum
Methodology : HPLC – High Performance Liquid Chromatography / DAD
TAT : 15 Days
The Fragile X (FMR1) Mutation Screen (L) is a genetic test designed to detect mutations in the FMR1 gene, which are associated with Fragile X syndrome, a leading cause of inherited intellectual disability and autism. This screening identifies CGG repeat expansions, distinguishing between normal, premutation, and full mutation alleles. Key benefits include early detection for informed reproductive decisions, risk assessment for carriers, and guidance for personalized medical management. Utilizing advanced molecular techniques, the test ensures high accuracy and reliability. Ideal for individuals with a family history of Fragile X or unexplained developmental delays, this screening provides critical genetic insights for proactive healthcare planning.
Immunohistochemical (IHC) Stain tests are advanced diagnostic tools used to detect specific antigens in tissue samples, aiding in disease diagnosis, particularly cancer. These tests utilize highly specific antibodies to identify cellular markers, enabling precise differentiation between tissue types and disease states.
Sample Type : Paraffin Embedded Block/Charged Slides
Methodology : Immunohistochemical
TAT : 5 days
Sample Type : Serum
Methodology : Nephelometry
TAT : 10 Days
The Jak 2 Exon 12-15 Mutation Analysis is a specialized genetic test designed to detect mutations in exons 12-15 of the JAK2 gene, which are associated with myeloproliferative neoplasms (MPNs) such as polycythemia vera (PV) and other hematologic disorders. This test offers high sensitivity and specificity, enabling early and accurate diagnosis, which is crucial for targeted treatment decisions and disease monitoring. Unlike standard JAK2 V617F mutation tests, this analysis identifies rare but clinically significant mutations, providing comprehensive genetic profiling for patients with suspected MPNs. Its advanced molecular technology ensures reliable results, supporting personalized therapeutic strategies and improving patient outcomes.
Sample Type : Whole Blood
Methodology : Inductively Coupled Plasma-Mass Spectrometry (ICP-MS)
TAT : 10 Days
Sample Type : Serum
Methodology : Enzyme-immunoassay
TAT : 10 Days
Sample Type : Plasma
Methodology : Spectrophotometry
TAT : 10 Days
